Travellers' diarrhoea - pros and cons of different prophylactic measures
- PMID: 19915810
- DOI: 10.1007/s00508-009-1228-1
Travellers' diarrhoea - pros and cons of different prophylactic measures
Abstract
Travellers' diarrhoea is the most likely cause for disturbing travel arrangements. At an average, 30-40% of tourists are concerned, depending on the travel destination. Due to the high impact on the travellers' health this topic is still of utmost importance in travel medicine. A wide spectrum of enteropathogens can be accountable, with enterotoxigenic Escherichia coli being the major causing pathogen among other bacteria, parasites and viruses. Here we discuss advantages and disadvantages of different prophylactic measures against travellers' diarrhoea. The effectiveness but also the relevance of hygiene education, vaccination and antibiotic or probiotic application will be discussed in the context of the travellers' different risk profiles.
Similar articles
-
Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia.J Travel Med. 2017 Sep 1;24(5). doi: 10.1093/jtm/tax056. J Travel Med. 2017. PMID: 28931148
-
Travellers' diarrhoea: contemporary approaches to therapy and prevention.Drugs. 2006;66(3):303-14. doi: 10.2165/00003495-200666030-00003. Drugs. 2006. PMID: 16526819 Review.
-
Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.Travel Med Infect Dis. 2007 Nov;5(6):380-4. doi: 10.1016/j.tmaid.2007.06.001. Epub 2007 Jul 30. Travel Med Infect Dis. 2007. PMID: 17983977
-
Travellers' diarrhoea and the effect of pre-travel health advice in general practice.Br J Gen Pract. 1997 Feb;47(415):71-5. Br J Gen Pract. 1997. PMID: 9101688 Free PMC article.
-
Travellers' diarrhoea.Int J Antimicrob Agents. 2003 Feb;21(2):116-24. doi: 10.1016/s0924-8579(02)00282-0. Int J Antimicrob Agents. 2003. PMID: 12615374 Review.
Cited by
-
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.Vaccine. 2020 Jul 6;38(32):5027-5035. doi: 10.1016/j.vaccine.2020.05.039. Epub 2020 Jun 11. Vaccine. 2020. PMID: 32536545 Free PMC article.
-
Chemoprophylaxis of Tropical Infectious Diseases.Pharmaceuticals (Basel). 2010 May 18;3(5):1561-1575. doi: 10.3390/ph3051561. Pharmaceuticals (Basel). 2010. PMID: 27713318 Free PMC article. Review.
-
Immunization in travel medicine.Prim Care. 2011 Dec;38(4):643-79, viii. doi: 10.1016/j.pop.2011.07.005. Prim Care. 2011. PMID: 22094138 Free PMC article. Review.
-
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.Cochrane Database Syst Rev. 2013 Jul 5;2013(7):CD009029. doi: 10.1002/14651858.CD009029.pub2. Cochrane Database Syst Rev. 2013. PMID: 23828581 Free PMC article.
-
Pathogen-induced secretory diarrhea and its prevention.Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1721-1739. doi: 10.1007/s10096-016-2726-5. Epub 2016 Jul 29. Eur J Clin Microbiol Infect Dis. 2016. PMID: 27473379 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous